" According to the latest report published by Data Bridge Market Research, the Asia-Pacific Alpha and Beta Emitters Based Radiopharmaceuticals Market The Asia-Pacific alpha and beta emitters based radiopharmaceuticals market size was valued at USD 168.86 million in 2024 and is expected to reach USD 358.95 million by 2032, at a CAGR of 9.9% during the...

" According to the latest report published by Data Bridge Market Research, the Middle East and Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market The Middle East and Africa alpha and beta emitters based radiopharmaceuticals market size was valued at USD 30.85 million in 2024 and is expected to reach USD 63.69 million by 2032, at a CAGR of...

" According to the latest report published by Data Bridge Market Research, the North America Alpha and Beta Emitters Based Radiopharmaceuticals Market The North America alpha and beta emitters based radiopharmaceuticals market size was valued at USD 339.33 million in 2024 and is expected to reach USD 783.52 million by 2032, at a CAGR of 11.1% during the...

North America is expected to remain a significant region in the alpha emitters market through 2034, supported by the growing adoption of targeted alpha therapies, increasing investment in radiopharmaceutical research, and advancements in nuclear medicine. The region benefits from a well-established healthcare infrastructure, strong pharmaceutical and biotechnology capabilities, and substantial...